View in EDS HTML Full Text PDF Full Text

NALCN Promoter Methylation as a Biomarker for Metastatic Risk in a Cohort of Non-Small Cell Lung Cancer Patients.

Saved in:
Bibliographic Details
Title: NALCN Promoter Methylation as a Biomarker for Metastatic Risk in a Cohort of Non-Small Cell Lung Cancer Patients.
Authors: Thanou, Eleni1 (AUTHOR) elenathanou99@gmail.com, Lontra, Dora1 (AUTHOR) doralontra@hotmail.gr, Balgouranidou, Ioanna2 (AUTHOR) ioannabalg@gmail.com, Efthimiadou, Eleni3 (AUTHOR) efthim@chem.uoa.gr, Delipetrou, Alexandra1 (AUTHOR) alexdelipetrou@gmail.com, Tsaroucha, Emilia4 (AUTHOR) emilygeola@yahoo.gr, Theodosiou, Maria3 (AUTHOR) mtheodoss@chem.uoa.gr, Georgoulias, Vassilis5 (AUTHOR) georgulv@otenet.gr, Kotsakis, Athanasios6 (AUTHOR) thankotsakis@hotmail.com, Lianidou, Evi1 (AUTHOR) lianidou@chem.uoa.gr, Markou, Athina1 (AUTHOR) atmarkou@chem.uoa.gr
Source: Biomolecules (2218-273X). Dec2024, Vol. 14 Issue 12, p1514. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:2218273X
DOI:10.3390/biom14121514